KYMR
Kymera Therapeutics Inc
NASDAQ: KYMR · HEALTHCARE · BIOTECHNOLOGY
$81.51
-2.79% today
Updated 2026-04-29
Market cap
$6.65B
P/E ratio
—
P/S ratio
169.71x
EPS (TTM)
$-3.69
Dividend yield
—
52W range
$28 – $103
Volume
0.7M
Kymera Therapeutics Inc (KYMR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-14.7%
Last 4 quarters
Revenue YoY growth
-61.3%
Most recent quarter
EPS YoY growth
-9.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.6%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-1.8%
2025-08-11
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-0.97 | -22.8% | $90.68 | $91.35 | +0.7% |
| 2025-10-29 | $-0.94 | -9.1% | $61.95 | $61.44 | -0.8% |
| 2025-08-11 | $-0.95 | -14.5% | $40.62 | $39.87 | -1.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.79 | $-0.97 | -22.8% | $2.86M | -61.3% |
| 2025-09-30 | $-0.86 | $-0.94 | -9.1% | $2.76M | -26.1% |
| 2025-06-30 | $-0.83 | $-0.95 | -14.5% | $11.48M | -55.3% |
| 2025-03-31 | $-0.73 | $-0.82 | -12.3% | $22.10M | +114.8% |
| 2024-12-31 | $-0.79 | $-0.89 | -12.9% | $7.39M | -84.6% |
| 2024-09-30 | $-0.84 | $-0.82 | +2.4% | $3.74M | -20.9% |
| 2024-06-30 | $-0.68 | $-0.58 | +14.7% | $25.65M | +55.3% |
| 2024-03-31 | $-0.73 | $-0.62 | +15.1% | $10.29M | — |
| 2023-12-31 | $-0.40 | $-0.25 | +37.5% | $47.88M | — |
| 2023-09-30 | $-0.64 | $-0.90 | -40.6% | $4.73M | — |
| 2023-06-30 | $-0.71 | $-0.67 | +5.6% | $16.51M | — |
Frequently asked questions
Has Kymera Therapeutics Inc beaten earnings estimates?
Kymera Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -14.7% over the last 4 quarters.
How does KYMR stock react to earnings?
KYMR stock has moved an average of -0.6% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Kymera Therapeutics Inc's revenue growth rate?
Kymera Therapeutics Inc reported year-over-year revenue growth of -61.3% in its most recent quarter, with EPS growing -9.0% year-over-year.